APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 29 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $371,070 | -48.3% | 300,000 | 0.0% | 0.01% | -42.9% |
| Q2 2023 | $717,076 | +28.6% | 300,000 | 0.0% | 0.01% | +27.3% |
| Q1 2023 | $557,437 | +21.1% | 300,000 | 0.0% | 0.01% | +22.2% |
| Q4 2022 | $460,312 | -21.0% | 300,000 | 0.0% | 0.01% | -30.8% |
| Q3 2022 | $583,000 | +30.1% | 300,000 | 0.0% | 0.01% | +44.4% |
| Q2 2022 | $448,000 | -5.7% | 300,000 | 0.0% | 0.01% | +12.5% |
| Q1 2022 | $475,000 | +4.6% | 300,000 | 0.0% | 0.01% | +14.3% |
| Q4 2021 | $454,000 | +23.4% | 300,000 | 0.0% | 0.01% | +16.7% |
| Q3 2021 | $368,000 | -33.5% | 300,000 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $553,000 | +31.4% | 300,000 | 0.0% | 0.01% | +14.3% |
| Q1 2021 | $421,000 | -16.3% | 300,000 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $503,000 | +56.7% | 300,000 | 0.0% | 0.01% | +50.0% |
| Q3 2020 | $321,000 | – | 300,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 39,528,000 | $49,938,921 | 2.17% |
| LINDEN ADVISORS LP | 15,000,000 | $18,816,676 | 0.19% |
| Verition Fund Management LLC | 12,454 | $15,645,338 | 0.18% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $14,863,606 | 0.17% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,017,000 | $1,284,573 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 12,242,000 | $15,379 | 0.02% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $371,070 | 0.01% |
| D. E. Shaw & Co., Inc. | 5,000,000 | $6,267,238 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 504,000 | $623,398 | 0.00% |